Overview Financials News + Filings Key Docs Charts Insiders |
Envision Healthcare Corp (EMS)
|
Add to portfolio |
|
|
Price: |
$4.95
| | Metrics |
OS: |
181.1
|
M
| |
3
|
% ROE
|
Market cap: |
$897
|
M
| |
36
|
% ROIC
|
Net debt:
|
$1.71
|
B
| |
3.8
|
x Debt/EBITDA
|
EV:
|
$2.61
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$447
|
M
| |
5.8
|
x EV/EBITDA
|
EBIT
|
$288
|
M
| |
9.1
|
x EV/EBIT
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
Revenues | 3,728.3 | 3,300.1 | 2,859.3 | 2,569.7 | 2,409.9 | 2,107.0 | 1,934.2 | 1,655.5 |
Revenue growth | 13.0% | | 11.3% | 6.6% | 14.4% | 8.9% | 16.8% | |
Cost of goods sold | 3,092.3 | 2,729.1 | 359.3 | 334.3 | 383.4 | 317.5 | 294.8 | 233.1 |
Gross profit | 636.0 | 571.1 | 2,500.1 | 2,235.4 | 2,026.5 | 1,789.5 | 1,639.4 | 1,422.4 |
Gross margin | 17.1% | 17.3% | 87.4% | 87.0% | 84.1% | 84.9% | 84.8% | 85.9% |
Selling, general and administrative | 106.7 | 78.5 | 67.9 | 63.5 | 69.7 | 61.9 | 57.4 | 54.3 |
EBITA | 359.4 | 338.4 | 246.0 | 213.1 | 168.2 | 134.8 | 108.1 | 81.1 |
EBITA margin | 9.6% | 10.3% | 8.6% | 8.3% | 7.0% | 6.4% | 5.6% | 4.9% |
Amortization of intangibles | 76.7 | 67.2 | | | | | | |
EBIT | 282.7 | 271.2 | 246.0 | 213.1 | 168.2 | 134.8 | 108.1 | 81.1 |
EBIT margin | 7.6% | 8.2% | 8.6% | 8.3% | 7.0% | 6.4% | 5.6% | 4.9% |
Pre-tax income | 10.2 | 68.3 | 210.5 | 180.6 | 137.1 | 95.1 | 63.6 | 34.4 |
Income taxes | -1.0 | 27.5 | 79.1 | 65.7 | 52.5 | 36.1 | 25.0 | 14.4 |
Tax rate | | 40.2% | 37.6% | 36.4% | 38.3% | 38.0% | 39.2% | 41.8% |
Net income | 6.0 | 41.2 | 131.7 | 115.2 | 84.8 | 59.8 | 39.1 | 20.1 |
Net margin | 0.2% | 1.2% | 4.6% | 4.5% | 3.5% | 2.8% | 2.0% | 1.2% |
|
Diluted EPS | $0.04 | $0.31 | | | $1.97 | $1.39 | $0.92 | $0.59 |
Shares outstanding (diluted) | 157.0 | 132.9 | | | 43.1 | 43.1 | 42.5 | 34.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|